Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms

Diagnostic Microbiology and Infectious Disease

Volumn 66, Issue 1, 2010, Pages 1-6

  Lepelletier, Didier ^a,b   Cady, Anne ^a   Caroff, Nathalie ^a,b   Marraillac, Julie ^a   Reynaud, Alain ^a,b   Lucet, Jean Christophe ^c   Corvec, Stéphane ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

case control study; gastrointestinal carriage; Imipenem resistance; Pseudomonas aeruginosa

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; IMIPENEM; PORIN; PORIN OPRD; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; GENE SEQUENCE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; INTESTINE FLORA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR;

EID: 71249096041     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.08.014     Document Type: Article

References (24)

1. Bertrand X., Thouverez M., Talon D., Boillot A., Capellier G., Florit C., and Hélias J.P. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care unit. Intensive. Care Med. 27 (2001) 1263-1268
2. Bonten M.J., Bergmans D.C., Speijer H., and Stobberingh E.E. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control. Am. J. Respir. Crit. Care Med. 160 (1999) 1212-1219
3. Cailleaux V., Mulin B., Capellier G., Julliot M.C., Thouverez M.E., and Talon D. Epidemiological study of variations in beta-lactam antibiotic susceptibility of Pseudomonas aeruginosa in two intensive care units. J. Hosp. Infect. 37 (1997) 217-224
4. Carmeli Y., Troillet N., Eliopoulos G.M., and Samore M.H. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob. Agents Chemother. 43 (1999) 1379-1382
5. Corvec S., Poirel L., Espaze E., Giraudeau C., Drugeon H., and Nordmann P. Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme. J. Hosp. Infect. 68 (2008) 73-82
6. Defez C., Fabbro-Peray P., Bouziges N., Gouby A., Mahamat A., Daures J.P., and Sotto A. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J. Hosp. Infect. 57 (2004) 209-216
7. Edlund C., and Nord C.E. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J. Antimicrob. Chemother. 46 Suppl (2000) 41-48
8. Filius P.M., Gyssens I.C., Kershof I.M., Roovers P.J., Ott AVulto A.G., Verbrugh H.A., and Endtz H.P. Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization. Antimicrob. Agents Chemother. 49 (2005) 2879-2886
9. Gutiérez O., Juan C., Pérez J.L., and Oliver A. Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob. Agents Chemother. 48 (2004) 3573-3575
10. Harris A.D., Karchmer T.B., Carmeli Y., and Samore M.H. Methodological principles of case-control studies that analyzed risk factors for antibiotics resistance: a systematic review. Clin. Infect. Dis. 32 (2001) 1055-1061
11. Harris A.D., Samore M.H., Lipsitch M., Kaye K.S., Perencevich E., and Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin. Infect. Dis. 34 (2002) 1558-1563
12. Harris A.D., Smith D., Johnson J.A., Bradham D.D., and Roghmann M.C. Risk factors for imipene`m-resistant Pseudomonas aeruginosa among hospitalized patients. Clin. Infect. Dis. 34 (2002) 340-345
13. Kohler T., Michea-Hamzehpour M., Epp S.F., and Pechere J.C. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob. Agents. Chemother. 43 (1999) 424-427
14. Lautenbach E., Weiner M.G., Nachamkin I., Bilker W.B., Sheridan A., and Fishman N.O. Imipenem resistance among Pseudomonas aeruginosa isolates: risk factor for infection and impact of resistance on clinical and economic outcomes. Infect. Control Hosp. Epidemiol. 27 (2006) 893-900
15. Lepelletier D., Caroff N., Riochet D., Bizouarn P., Bourdeau A., Le Gallou F., Espaze E., Reynaud A., and Richet H. Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastro-intestinal colonization in hospital patients: a prospective study. Eur. J. Clin. Microbiol. Infect. Dis. 25 (2006) 600-603
16. Mueller M.R., Hayden M.K., Fridkin S.K., Warren D.K., Philipps L., Lolans K., and Quinn J.P. Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysis. Eur. J. Clin. Microbiol. Infect. Dis. 27 (2008) 565-570
17. Murthy S.K., Baltc A.L.h., Smith R.P., Desjardin E.K., Hammer M.C., Conroy J.V., and Michelsen P.B. Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients. J. Clin. Microbiol. 27 (1989) 35-40
18. Peña C., Guzman A., Suarez C., Dominguez M.A., Tubau F., Pujol M., Gudiol F., and Ariza J. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients. Antimicrob. Agents Chemother. 51 (2007) 1967-1971
19. Pirnay J.P., De Vos D., Cochez C., Bilocq F., Vanderkelen A., Zizi M., Ghysels B., and Cormelis P. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ. Microbiol. 4 (2002) 872-882
20. Quinn J.P., Dudek E.J., DiVincenzo C.A., Lucks D.A., and Lerner S.A. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J. Infect. Dis. 154 (1986) 289-294
21. Sullivan A., Edlund C., and Nord C.E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1 (2001) 101-114
22. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DAN restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbial. 33 (1995) 2233-2239
23. Wolter D.J., Hanson N.D., and Lister P.D. Insertional inactivation of OprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS. Microbiol. Lett. 236 (2004) 137-143
24. Zavascki A.P., Cruz R.P., and Goldani L.Z. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J. Hosp. Infect. 59 (2005) 96-101